Can a patient who has been taking cyclobenzaprine 10 mg daily for several years split the tablet to obtain a half dose?

Can You Cut Cyclobenzaprine in Half?

Yes, cyclobenzaprine 10 mg tablets can be split in half to achieve a 5 mg dose, which is actually the FDA-recommended starting dose for most patients, but be aware that splitting unscored tablets results in significant dose variability that may affect therapeutic response.

FDA-Approved Dosing Supports Half-Dose Strategy

The FDA label explicitly recommends 5 mg three times daily as the starting dose for most patients, with the option to increase to 10 mg three times daily based on individual response 1. This validates the clinical rationale for obtaining a 5 mg dose. Additionally, the label specifically recommends lower dosing for elderly or hepatically impaired patients 1, making dose reduction particularly important in these populations.

Critical Caveat: Dose Variability with Tablet Splitting

The major concern is dose accuracy. Research demonstrates that splitting unscored cyclobenzaprine 10 mg tablets produces highly variable fragment weights:

• Using a tablet splitter: Fragment weights ranged from 69.4% to 130.2% of target weight, corresponding to estimated drug content between 3.47 mg and 6.51 mg (target: 5 mg) 2
• Hand splitting: Even worse variability, with fragments ranging from 49.9% to 149.5% of target weight, corresponding to 2.49 mg to 7.48 mg 2

This 23.2% relative standard deviation with hand splitting versus 11.6% with a device means unpredictable dosing and therapeutic response 2.

Clinical Implications

When Splitting Is Reasonable:

• Patient has been stable on 10 mg daily for years (as in your scenario)
• Goal is dose reduction due to side effects (drowsiness, dry mouth, dizziness—which occur in 29%, 21%, and 11% respectively at 10 mg) 1
• Patient can tolerate some dose variability without significant clinical consequences
• Cyclobenzaprine has a relatively wide therapeutic window (not a narrow therapeutic index drug)

Practical Approach:

1. Use a tablet splitting device rather than hand splitting—this reduces variability by approximately 50% 2, 3
2. Monitor for withdrawal symptoms if reducing from long-term use: malaise, nausea, and headache lasting 2-4 days are possible but not life-threatening 4
3. Consider tapering over 2-3 weeks if discontinuing entirely to prevent withdrawal 4
4. Watch for return of muscle spasm symptoms with the lower dose

Better Alternatives:

• Request a prescription for 5 mg tablets if available—this eliminates dose variability entirely
• The 5 mg dose has been proven equally effective to 10 mg three times daily in clinical trials, with significantly less sedation (29% vs 38% drowsiness) 1, 5

Important Safety Considerations

Cyclobenzaprine is listed in the 2019 Beers Criteria as potentially inappropriate in older adults due to anticholinergic effects and CNS adverse effects including sedation, confusion, and fall risk 6, 7. If your patient is elderly, splitting to achieve a lower dose is particularly justified, though deprescribing entirely should be considered after several years of use 7.

The drug should be held on the day of any surgical procedure due to interactions with sedatives and anesthetic agents 4.

Bottom Line

Splitting is feasible but imperfect. For a patient stable on chronic therapy seeking dose reduction, using a tablet splitter to obtain approximate 5 mg doses is reasonable, accepting that individual doses will vary by ±30-50%. The therapeutic benefit of dose reduction (less sedation, fewer anticholinergic effects) likely outweighs the risk of dose variability for this medication. However, obtaining properly manufactured 5 mg tablets is the superior option if available.